Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Premium

Register

Sign In

EUR/USD

1.2288

-0.0056

-0.45%

GBP/USD

1.4003

-0.0079

-0.56%

USD/JPY

107.65

0.2200

0.20%

USD/CHF

0.9750

0.0033

0.34%

EUR/GBP

0.8774

0.0009

0.10%

USD/CAD

1.2765

0.0100

0.79%

NZD/USD

0.7208

-0.0057

-0.78%

EUR/JPY

132.29

-0.3180

-0.24%

EUR/CHF

1.1980

-0.0014

-0.12%

AC Immune Sa

NASDAQ: ACIUHealthcare / Biotechnology / Switzerland
10.42-0.10-0.95%Vol 47 8171Y Perf 4.87%
Apr 20th, 2018 16:00
BID10.34 ASK10.47
Open10.36 Previous Close10.52
Pre-Market- After-Trading-
 - -%  - -%
Target Price
22.00 
Analyst Rating
Strong Buy 1.00
Potencial %
111.13 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
★★+     50.10
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★+ —    47.65
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)598 
Earnings Rating
Price Range Ratio 52wk %
55.71 
Earnings Date
10th May 2018

Today's Price Range

9.5310.55

 

52wk Range

6.0313.91

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
-16.97%
3 Months
-20.70%
6 Months
-12.22%
1 Year
4.87%
3 Years
-
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
ACIU10.42-0.1000-0.95
AAPL165.72-7.0800-4.10
GOOG1 072.96-14.7400-1.36
MSFT95.00-1.1100-1.15
XOM79.00-0.4200-0.53
WFC52.561.02001.98
JNJ126.66-0.8900-0.70
FB166.28-1.8200-1.08
GE14.540.55003.93
JPM111.47-0.2500-0.22
...

TickerPriceChg.%52 Week High
RF18.894.0820.21
XRX31.543.9937.42
GE14.543.9330.38
HRB27.102.9231.80
ETFC60.482.8061.80
SCHW54.992.4458.11
SIG38.652.1777.94
UAL71.752.1683.04
WFC52.561.9866.31
RE246.991.91277.17
M29.961.8731.04
CTL17.611.6727.61
HON150.571.65165.13
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 13.10
Current Ratio 13.30
Long Term Debt to Total Capital 0.00
Total Debt to Equity 0.00
Interest Coverage -178.70
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-379.60
EBITDA Margin-373.00
Pre-tax Profit Margin-
Profit Margin-94.09
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 4.22
PS Ratios 27.30
Price to Cash Flow 35.80
Price to Free Cash Flow -42.50
Cash Flow Per Share -0.40
Price to Tangible Book4.28
Book Value per Share2.12
Enterprise Value (in ths.)383 926
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -20.87
Return on Assets (5Y Avg) -
ROA last 12 Months -18.77
Return on Capital (5Y Avg) -
ROC last 12 Months -10.31
Return on invested Capital Q 3.67
Return on invested Capital Y-20.46
Assets Turnover0.10
Receivables Turnover7.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)18 785
Revenue per Share 0.33
Revenue Growth 3 Years -19.26
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q04 2017-0.06-
Q03 2017-0.20-0.1620.00
Q02 2017-0.07-0.22-214.29
Q01 2017-0.17-0.170.00
----
----
----
----
Earnings Per EndEstimateRevision %Trend
3/2018 QR-0.22-120.00Negative
6/2018 QR-0.22-100.00Negative
12/2018 FY-1.06-85.96Negative
12/2019 FY-1.139.60Positive
Next Report Date10th May 2018
Estimated EPS Next Report-0.22
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume47 817
Shares Outstanding (in ths.)57 350
Trades Count212
Dollar Volume440 698
Avg. Volume62 271
Avg. Weekly Volume43 085
Avg. Monthly Volume52 001
Avg. Quarterly Volume64 145

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

57%43%

Bearish Bullish

75%25%

Bearish Bullish

83%17%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
1 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x